<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
  <title>The Tesla BioLights Journal</title>
  <link>https://www.teslabiolights.com/blog/</link>
  <description>Daily essays on biophotonic plasma therapy, PEMF, photobiomodulation, bioelectricity, and the 130-year scientific lineage from Tesla to Levin. Every article peer-reviewed.</description>
  <language>en-us</language>
  <lastBuildDate>Tue, 09 Jun 2026 08:00:00 +0000</lastBuildDate>
  <pubDate>Tue, 09 Jun 2026 08:00:00 +0000</pubDate>
  <generator>Tesla BioLights Static Blog</generator>
  <managingEditor>Doug@teslabiolights.com (Tesla BioLights)</managingEditor>
  <webMaster>Doug@teslabiolights.com (Tesla BioLights)</webMaster>
  <copyright>Copyright 2026 Tesla BioLights</copyright>
  <atom:link href="https://www.teslabiolights.com/blog/feed.xml" rel="self" type="application/rss+xml" />
  <image>
    <url>https://www.teslabiolights.com/assets/logo/logo-mark-2x.png</url>
    <title>The Tesla BioLights Journal</title>
    <link>https://www.teslabiolights.com/blog/</link>
  </image>
  <ttl>1440</ttl>

  <item>
    <title>The Anti-Inflammatory Mechanisms of Photobiomodulation: The Hamblin Reviews</title>
    <link>https://www.teslabiolights.com/blog/anti-inflammatory-mechanisms-photobiomodulation-hamblin-reviews/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/anti-inflammatory-mechanisms-photobiomodulation-hamblin-reviews/</guid>
    <pubDate>Tue, 09 Jun 2026 08:00:00 +0000</pubDate>
    <category>PBM</category>
    <category>Anti-Inflammatory Mechanism</category>
    <category>Hamblin</category>
    <category>Masterpiece</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description>The most carefully characterized anti-inflammatory mechanism in the entire wellness-photonic category. Michael Hamblin's three-decade body of work at Harvard / Wellman Center — synthesized in the 2016 IEEE Proposed Mechanisms review (PMID 28070154) and the 2017 AIMS Biophysics Mechanisms and Applications paper (PMC5523874). The eight-step molecular cascade: cytochrome c oxidase photon absorption → nitric oxide displacement → mitochondrial ATP boost → biphasic reactive oxygen species signaling → Nrf2 antioxidant master regulator activation → NF-κB transcription factor downregulation → macrophage M1-to-M2 polarization shift → cytokine cascade modulation (TNF-α, IL-6, IL-1β suppression; IL-10 elevation). Clinical translations across musculoskeletal pain (Cochrane), oral mucositis (MASCC/ISOO Category I), wound healing, periodontitis, and emerging neuroinflammation research. Every claim PMID-cited.</description>
  </item>

  <item>
    <title>The Lineage in One Image: 130 Years of Bioelectric Medicine, Tesla to Levin</title>
    <link>https://www.teslabiolights.com/blog/lineage-tesla-lakhovsky-priore-popp-levin-130-years-bioelectric-medicine/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/lineage-tesla-lakhovsky-priore-popp-levin-130-years-bioelectric-medicine/</guid>
    <pubDate>Mon, 08 Jun 2026 08:00:00 +0000</pubDate>
    <category>Lineage</category>
    <category>Synthesis</category>
    <category>130 Years</category>
    <category>Masterpiece</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description>Tesla 1898 → Lakhovsky 1920s → Rife 1930s → Yasuda 1954 → Priore 1960s → Popp 1970s → Bassett 1974 → FDA-PEMF 1979 → NIH biofield 1994 → Engel 2007 → Levin 2010s → modern wellness-technology renaissance. Each name is a node on one continuous research arc. This essay integrates the prior Day 6 through Day 11 individual profiles — plus the subsequent FDA-PEMF (Day 17), NIH-biofield (Day 20), and quantum-biology (Day 16) integration essays — into a single chronological synthesis. Three interlocking 130-year research questions: how electromagnetic exposure affects tissue, whether cells emit measurable photons in non-random patterns, and whether bioelectric state controls morphology. All three converge on the wellness-experiential modality category Tesla BioLights inherits. The lineage Tesla BioLights stands on, told as one story.</description>
  </item>

  <item>
    <title>Pre-Session and Post-Session Reports: What People Actually Notice</title>
    <link>https://www.teslabiolights.com/blog/pre-post-session-reports-what-people-notice-tesla-biolights-experience/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/pre-post-session-reports-what-people-notice-tesla-biolights-experience/</guid>
    <pubDate>Sun, 07 Jun 2026 08:00:00 +0000</pubDate>
    <category>Experience</category>
    <category>Qualitative Reports</category>
    <category>Honest Epistemics</category>
    <category>Masterpiece</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description>The honest qualitative companion to the quantitative-physiology essay. What Tesla BioLights users actually report across the immediate 0-30 minute post-session window, the 24-hour next-day window, and the multi-session arc. Plus the rare patterns, the negative reports, and the careful epistemic framing of what subjective reports do and do not establish. Informed by Jain &amp; Mills 2010 biofield best-evidence synthesis, Kaptchuk Harvard open-label placebo research, the FDA patient-reported outcome framework, and the qualitative-research methodology canon.</description>
  </item>

  <item>
    <title>How a 15-Minute Tesla BioLights Session Works, Bioelectrically</title>
    <link>https://www.teslabiolights.com/blog/how-tesla-biolights-session-works-bioelectric-minute-by-minute/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/how-tesla-biolights-session-works-bioelectric-minute-by-minute/</guid>
    <pubDate>Sat, 06 Jun 2026 08:00:00 +0000</pubDate>
    <category>S.E.A.D. System</category>
    <category>Session Physiology</category>
    <category>Autonomic Nervous System</category>
    <category>Masterpiece</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description>A minute-by-minute physiological walkthrough of a 15-minute Tesla BioLights S.E.A.D. session, mapped against the peer-reviewed photobiomodulation, autonomic-nervous-system, and PEMF literature. Vagal priming (Porges), broadband photonic dose across the 600–1100 nm optical window (Karu, Hamblin), cytochrome c oxidase ATP signature, PEMF field profile (Bassett, Pilla), HRV shift toward high-frequency vagal dominance (Lehrer-Gevirtz, McCraty, Shaffer), cholinergic anti-inflammatory reflex (Tracey 2000 Nature), and the post-session integration window. The device user manual translated into peer-reviewed physiology.</description>
  </item>

  <item>
    <title>The Coherence Question: Are Biophotons Lasers or Light Bulbs?</title>
    <link>https://www.teslabiolights.com/blog/coherence-question-biophotons-popp-photon-statistics/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/coherence-question-biophotons-popp-photon-statistics/</guid>
    <pubDate>Fri, 05 Jun 2026 08:00:00 +0000</pubDate>
    <category>Biophotonics</category>
    <category>Photon Statistics</category>
    <category>Quantum Coherence</category>
    <category>Masterpiece</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description>In 1976 Fritz-Albert Popp pointed a photomultiplier tube at a living cucumber seedling and discovered photon-counting statistics that did not match Poisson — they were sub-Poissonian, the signature of coherent light. Forty years later that single observation remains the most consequential and most contested claim in biophotonics. This essay walks through the three distinct meanings of &quot;coherent&quot;, Popp&apos;s 1984 Cell Biophysics paper, Bajpai&apos;s squeezed-state formalism, the Van Wijk Utrecht continuations, the Cifra &amp; Pospíšil 2014 field-consensus review, the Engel 2007 Nature paper on photosynthetic quantum coherence, and the honest 2026 scientific reading.</description>
  </item>

  <item>
    <title>Cold Atmospheric Plasma in Medicine: The Clinical Field That Validated the Physics</title>
    <link>https://www.teslabiolights.com/blog/cold-atmospheric-plasma-medicine-clinical-research/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/cold-atmospheric-plasma-medicine-clinical-research/</guid>
    <pubDate>Thu, 04 Jun 2026 08:00:00 +0000</pubDate>
    <category>Plasma Medicine</category>
    <category>Clinical Research</category>
    <category>CE-Marked Devices</category>
    <category>Masterpiece</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[In 2005, the Leibniz Institute for Plasma Science and Technology in Greifswald, Germany opened a research program with a deliberately ambitious name: plasma medicine. Two decades later, that name is the title of a peer-reviewed journal, a clinical specialty taught in German medical schools, and a regulatory category under which more than a dozen CE-marked medical devices are now in routine European hospital use. This essay traces the field's complete trajectory: the founding under Klaus-Dieter Weltmann and Thomas von Woedtke at INP Greifswald; the wound-healing evidence base (Isbary et al. 2012 British Journal of Dermatology on MRSA chronic wounds with the MicroPlaSter device, Brehmer et al. 2015 J Eur Acad Dermatol Venereol on the PlasmaDerm VU-2010 dielectric-barrier-discharge device in chronic venous leg ulcers); dermatology applications (atopic dermatitis, onychomycosis, acne); dental applications (root canal sterilization, periodontitis adjunct); the Metelmann 2018 Clinical Plasma Medicine head and neck cancer palliation trial at Greifswald University Medicine; the Michael Keidar in vitro selectivity research at George Washington University; the comprehensive Sander Bekeschus plasma-oncology body of work; the canonical Kong 2009 New Journal of Physics introductory review (Morfill, Shimizu, Zimmermann); the Graves 2012 J Phys D applied physics RONS-mechanism reference; the CE-marked device landscape (kINPen MED from neoplas tools, PlasmaDerm VU-2010 from CINOGY, SteriPlas from Adtec Healthcare); the FDA trajectory beginning with the Apyx Medical Renuvion 510(k) clearance in 2020 for cosmetic surgical use; and the explicit framing of what clinical plasma medicine does and does not validate for the broader Tesla BioLights premise — shared underlying physics (ionized gas, electromagnetic excitation, characteristic emission spectra) but structurally different application architectures (clinical contact CAP versus sealed-tube non-contact wellness emission). The clinical field that validated the physics Tesla BioLights operates on at one structural remove.]]></description>
  </item>

  <item>
    <title>The Federal Word for It: How NIH's 1994 'Biofield' Term Legitimized the Tesla BioLights Category</title>
    <link>https://www.teslabiolights.com/blog/nih-biofield-term-1994-federal-research-category/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/nih-biofield-term-1994-federal-research-category/</guid>
    <pubDate>Wed, 03 Jun 2026 08:00:00 +0000</pubDate>
    <category>Federal Research</category>
    <category>Biofield</category>
    <category>NIH</category>
    <category>Masterpiece</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[In May 1994, a workshop convened by the National Institutes of Health's two-year-old Office of Alternative Medicine produced a single word — biofield — that would, three decades later, give every wellness-technology device in the bioenergetic category a federal vocabulary for what it was actually doing. This essay traces the term's complete history: Senator Tom Harkin's 1992 appropriations bill establishing the Office of Alternative Medicine with a $2M budget and a complementary/alternative medicine investigative mandate; the May 1994 OAM workshop chaired by Beverly Rubik that produced the working definition still in use thirty-two years later (the endogenous, complex dynamic electromagnetic field resulting from the superposition of component fields of the body's biological processes); the bureaucratic continuity from OAM through NCCAM (1998, $50M+ budget) to today's NCCIH (2014, $150M+ annually); the 2002 Beverly Rubik biofield hypothesis paper in J Altern Complement Med (PMID 12614524), grounding biofield concepts in established biophysics through endogenous electromagnetic fields measurable with conventional instrumentation (magnetocardiography, MEG, surface EMG); the 2010 Jain & Mills best-evidence synthesis in Int J Behav Med (PMID 19856109) covering 66 RCTs of biofield therapies with strong evidence for pain reduction, moderate for chronic pain and hospital anxiety; the 2012 Hammerschlag et al. methodological roundtable in JACM (PMID 23210463); the landmark 2015 Global Advances in Health and Medicine special issue on Biofield Science and Healing edited by Jain, Hammerschlag, Mills, Schwartz, and Yount; the federal funding record at Stanford School of Medicine, UC San Diego Jain lab, University of Arizona Schwartz lab, VA Healthcare System Whole Health initiative for nine million veterans, Department of Defense Helfgott Research Institute, and National Cancer Institute supportive oncology programs; and the explicit honest reading of what the federal vocabulary licenses (the research category itself, thirty-two years of continuous federal funding, institutional integration at Stanford / UCSF / UCSD / Yale / Duke / Mayo / Cleveland Clinic) versus what it does not license (any specific outcome claim, which requires its own evidence — the integrity boundary established in Days 17 and 18 of this Journal). Tesla BioLights sits openly inside the federally-coined biofield vocabulary, makes no medical claims, and operates in the wellness-experiential category that the NIH itself has named since 1994.]]></description>
  </item>

  <item>
    <title>Why Most Wellness Devices Aren't Tesla BioLights: A Comparative Anatomy</title>
    <link>https://www.teslabiolights.com/blog/tesla-biolights-vs-other-wellness-devices-comparison/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/tesla-biolights-vs-other-wellness-devices-comparison/</guid>
    <pubDate>Tue, 02 Jun 2026 08:00:00 +0000</pubDate>
    <category>Comparative</category>
    <category>Devices</category>
    <category>Integration</category>
    <category>Masterpiece</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[The comparative-anatomy masterpiece. An honest, respectful, rigorous mapping of every adjacent wellness-technology category against the seven scientific domains the Tesla BioLights S.E.A.D. System operates on. Categories analyzed: (1) Red-light therapy panels (Joovv, Mito Red Light, PlatinumLED, Lumebox, BlockBlueLight) — single or dual narrowband LED, FDA 510(k) cleared for various dermatologic indications, covers photobiomodulation only. (2) PEMF mats (BEMER, Pulsetto, OMI, Hugo, PEMF Supply) — descended from the 1979 Bassett FDA-cleared bone-non-union devices, covers PEMF + bioelectricity only. (3) BioCharger NG — the closest cousin to Tesla BioLights, also uses noble-gas plasma + high-voltage Tesla-style drive, different philosophical positioning around frequency-medicine programs. (4) Infrared saunas (Sunlighten, Clearlight, Higher Dose, JNH) — far-IR 3000-14000nm absorbed primarily by water not cytochrome c oxidase, mechanism is thermal not photochemical, Kuopio sauna cohort evidence base (Laukkanen 2015 JAMA Internal Medicine) is legitimately strong. (5) Transcutaneous vagus nerve stimulators (Cala, Parasym, gammaCore, Nemos) — FDA-cleared for migraine and essential tremor, directly stimulates the auricular branch of the vagus nerve, electrical not photonic. (6) Hyperbaric oxygen chambers — FDA-approved for 14 specific clinical indications, completely different mechanism. (7) Pneumatic compression boots (Normatec, Hyperice) — mechanical lymphatic return. Full coverage matrix mapping each device to the seven Tesla BioLights domains. Stack-versus-integrate user economics: stacking best-in-class devices for all seven domains costs approximately $8,700+ in equipment and 100 minutes per day; Tesla BioLights integrates into 15 minutes at one capital cost. Explicit "what Tesla BioLights is NOT" disclosure for integrity: not FDA-cleared for medical indication, not a replacement for clinical care, not single-modality, not quantum healing. The honest scientific reading: every device above is real and addresses something legitimate; the Tesla BioLights distinction is field-level integration rather than convenience stacking, an empirical question we have invited readers to test via the Day 18 HRV protocol.]]></description>
  </item>

  <item>
    <title>HRV, Light, and PEMF: How to Actually Measure the Parasympathetic Dose</title>
    <link>https://www.teslabiolights.com/blog/hrv-light-pemf-quantifying-parasympathetic-dose/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/hrv-light-pemf-quantifying-parasympathetic-dose/</guid>
    <pubDate>Sun, 31 May 2026 08:00:00 +0000</pubDate>
    <category>Methods</category>
    <category>HRV</category>
    <category>Quantification</category>
    <category>Masterpiece</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[The practical methods masterpiece. Every wellness claim worth taking seriously should be measurable. The Tesla BioLights premise rests on the proposition that a 15-minute non-contact session activates the parasympathetic nervous system — a testable claim. This essay walks through how to actually run that test at home with consumer-grade equipment. The heart-rate-variability metrics that matter (RMSSD as the primary time-domain measure, HF-HRV power as the frequency-domain parasympathetic readout, SDNN for long-term trending, why LF/HF ratio should be retired per Billman 2013 Front Physiol). The 1996 ESC/NASPE Task Force HRV standards document. The Shaffer & Ginsberg 2017 Frontiers in Public Health overview. The consumer wearable accuracy hierarchy: Polar H10 chest strap (ECG-grade, >99% vs Holter), Oura Ring (95% vs ECG overnight), Whoop, Apple Watch, Garmin. The Lehrer-Gevirtz 2014 Frontiers in Psychology resonance-frequency-breathing protocol — six breaths per minute (0.1 Hz) parks the HRV signal on the baroreflex resonance peak and controls the largest single confound in HRV measurement. The cortisol awakening response (Fries et al. 2009) as the slower-trending complementary measure. The complete 25-minute at-home pre/post protocol: 5-min seated baseline at 6 bpm → 15-min session → 5-min seated recovery at 6 bpm, primary metric RMSSD, meaningful effect size 10-30% increase. Common pitfalls (caffeine, time of day, position changes, breathing rate, single-day overinterpretation). The published PBM/PEMF + HRV literature (Sutbeyaz 2009 fibromyalgia, Thayer & Lane 2009 vagal tone reach, Russo et al. 2017 slow breathing physiology). Tesla BioLights's explicit falsifiability commitment: we are not afraid of the measurement, we invite users to run the protocol and send results — positive or null — to Doug@teslabiolights.com.]]></description>
  </item>

  <item>
    <title>FDA Clearance for PEMF Since 1979: What That Actually Means</title>
    <link>https://www.teslabiolights.com/blog/fda-cleared-pemf-1979-what-this-really-means/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/fda-cleared-pemf-1979-what-this-really-means/</guid>
    <pubDate>Sat, 30 May 2026 08:00:00 +0000</pubDate>
    <category>PEMF</category>
    <category>Regulatory</category>
    <category>Bone Healing</category>
    <category>Masterpiece</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[In November 1979 the FDA issued a 510(k) clearance to Electro-Biology Inc. for the Bone Growth Stimulator — the first pulsed electromagnetic field device authorized for marketing in American medicine. The indication was specific: long-bone non-union fractures defined as failure to heal after nine months of conventional treatment. Forty-seven years later the FDA database lists over a hundred subsequent 510(k) clearances for PEMF devices across spinal fusion adjunct, fresh tibial fracture, cervical fusion, post-surgical edema and pain, and wound healing. This essay walks through Iwao Yasuda's 1957 demonstration of piezoelectric properties in bone tissue at Kyoto, Andrew Bassett's 1974 Annals of the New York Academy of Sciences foundational paper at Columbia (with Pawluk and Pilla) that inverted the principle into external electromagnetic field induction, the technical distinction between FDA 510(k) clearance (substantial equivalence to a predicate device) and PMA premarket approval (full clinical efficacy validation) that most wellness marketing conflates, the 47 years of expanded indications, the Aaron-Pilla-Funk-Markov mechanism literature (transmembrane potential modulation via Faraday induction, voltage-gated calcium dynamics, A2A adenosine receptor signaling, BMP-2 and TGF-β upregulation in osteoblasts, ion cyclotron resonance theory from Liboff 1985), the Cochrane systematic review evidence (Hannemann 2014 on tibial fractures showing moderate-quality evidence for delayed unions), the modern synthesis (Funk & Monsees 2006 Cells Tissues Organs, Pilla 2013 Electromagnetic Biology and Medicine), the Optune (Novocure) Tumor Treatment Fields PMA approval as the highest-evidence PEMF-adjacent technology, and Tesla BioLights's careful disclosure: the device is NOT FDA-cleared as a PEMF therapy, the PEMF generated by the Tesla coil drive is a real physical phenomenon, and the underlying physics is the same physics underwriting 47 years of cleared clinical indications.]]></description>
  </item>

  <item>
    <title>The Quantum Floor: Coherence, Tunneling, and Spin Inside Living Tissue</title>
    <link>https://www.teslabiolights.com/blog/quantum-biology-coherence-tunneling-radical-pair-spin/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/quantum-biology-coherence-tunneling-radical-pair-spin/</guid>
    <pubDate>Fri, 29 May 2026 08:00:00 +0000</pubDate>
    <category>Quantum Biology</category>
    <category>Physics</category>
    <category>Coherence</category>
    <category>Masterpiece</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[The deepest physics essay in the Tesla BioLights Journal. In 1944, Erwin Schrödinger proposed in What Is Life? that biology would eventually require quantum-mechanical explanation. The molecular biology revolution that followed appeared to make the suggestion quaint. Across the past two decades the consensus cracked open in three carefully measured places, each now mainstream physics published in Nature and the Annual Reviews. (1) Quantum coherence in photosynthetic energy transfer: Engel et al. 2007 Nature on the Fenna-Matthews-Olson complex demonstrated 2D-electronic-spectroscopy beating signals consistent with wave-like excitation transfer, Panitchayangkoon et al. 2010 PNAS extended the result to physiological 277 K temperatures, Cao et al. 2020 Science Advances synthesized the field. Protein scaffolds evolved to preserve quantum superposition rather than destroy it. (2) Radical-pair magnetoreception: Schulten 1978 proposed that the singlet-triplet spin dynamics of light-induced radical pairs in cryptochrome could explain bird navigation by Earth-strength magnetic fields too weak for any classical mechanism. Hore & Mouritsen 2016 Annu Rev Biophys consolidated three decades of theory and animal-behavior evidence. Xu et al. 2021 Nature provided the direct biophysical demonstration in European robin cryptochrome 4. (3) Hydrogen tunneling in enzyme catalysis: Judith Klinman and collaborators at UC Berkeley established across two decades that protein conformational fluctuations gate quantum-mechanical tunneling of hydrogen atoms through enzyme transition-state barriers — alcohol dehydrogenase, soybean lipoxygenase, methylmalonyl-CoA mutase, dozens of systems with kinetic isotope effects too large for classical transition-state theory (Klinman & Kohen 2013 Annu Rev Biochem). The frontier extends to DNA charge transport (Barton at Caltech), olfactory vibrational sensing (Turin), microtubule quantum computation (Penrose-Hameroff Orch-OR), and biophoton coherence (Popp's sub-Poissonian statistics). The Marais et al. 2018 J R Soc Interface and Lambert et al. 2013 Nature Physics syntheses anchor the field as graduate-curriculum biophysics at Oxford, Berkeley, Caltech, and Cambridge. This essay walks through all three established cases, the active frontier, what quantum biology licenses for understanding Tesla BioLights (coherent photonic communication is physically plausible per Popp + FMO precedent; weak EM field bioeffects are established per cryptochrome; bioelectric ion channel substrate is implicit), and what it does not license (the word "quantum" as marketing token, specific therapeutic claims without measurement).]]></description>
  </item>

  <item>
    <title>The Vagal Path: How Light, Stillness, and the Parasympathetic Nervous System Quietly Run the Body</title>
    <link>https://www.teslabiolights.com/blog/vagus-nerve-light-parasympathetic-path/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/vagus-nerve-light-parasympathetic-path/</guid>
    <pubDate>Thu, 28 May 2026 08:00:00 +0000</pubDate>
    <category>Bioelectricity</category>
    <category>Autonomic Nervous System</category>
    <category>Polyvagal Theory</category>
    <category>Masterpiece</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[The masterpiece edition on the vagus nerve. The longest nerve in the human body, named for the Latin vagus — the wanderer — emerges from the medulla oblongata and reaches the heart, lungs, liver, spleen, and the entire gut. Of approximately one hundred thousand fibers in each vagal trunk, eighty thousand are afferent sensory fibers reporting visceral state to the brainstem and only twenty thousand are efferent parasympathetic motor fibers — making the vagus overwhelmingly the body's interoceptive sensory channel. This essay walks through the anatomy of the tenth cranial nerve, Stephen Porges's Polyvagal Theory and the three-state autonomic model (ventral vagal social engagement, sympathetic activation, dorsal vagal shutdown), Kevin Tracey's 2000 Nature discovery (Borovikova et al.) that direct vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin by suppressing TNF-α release through α7 nicotinic acetylcholine receptors on splenic macrophages, the synthesis review that named the cholinergic anti-inflammatory pathway (Tracey 2002 Nature), the bioelectronic medicine field that grew out of it (Pavlov & Tracey 2017 Nat Rev Endocrinol, SetPoint Medical rheumatoid arthritis trial Koopman 2016 PNAS), heart-rate variability as the non-invasive readout of vagal tone and the high-frequency 0.15-0.4 Hz band, the Lehrer-Gevirtz resonance-frequency-breathing literature establishing 6 breaths per minute (0.1 Hz) as the baroreflex resonance peak, the FDA-cleared landscape of vagus nerve stimulation across refractory epilepsy (Cyberonics 1997), treatment-resistant depression (2005), cluster headache and migraine (gammaCore 2017), and chronic stroke recovery (Vivistim VNS-REHAB trial 2021, Dawson et al. Lancet), the transcutaneous auricular VNS (taVNS) frontier exploiting the auricular branch innervation of the cymba conchae, the photobiomodulation-and-HRV literature, and the parasympathetic engineering argument for the Tesla BioLights session protocol — fifteen minutes, dim lighting, non-contact field, recline, calm environment — engaging three converging vagal channels (environmental Porges-style safety cueing, photobiomodulation via cytochrome c oxidase and NF-κB suppression, pulsed electromagnetic field autonomic modulation) at the same final common biology.]]></description>
  </item>

  <item>
    <title>The Inert Pharmacology: Xenon, Argon, and the Quiet Medicine of the Right-Hand Column</title>
    <link>https://www.teslabiolights.com/blog/inert-pharmacology-xenon-argon-noble-gas-medicine/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/inert-pharmacology-xenon-argon-noble-gas-medicine/</guid>
    <pubDate>Wed, 27 May 2026 08:00:00 +0000</pubDate>
    <category>Noble Gas Biology</category>
    <category>Pharmacology</category>
    <category>Neuroprotection</category>
    <category>Masterpiece</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[The longest and most-cited essay in the Tesla BioLights Journal. When Sir William Ramsay isolated the noble gases between 1894 and 1898, chemistry named them "inert" — closed valence shells, no bonds, no biology. That last part turned out to be wrong. This essay traces the forty-year mechanism story from Stuart Cullen and Erwin Gross's 1951 first xenon anesthesia at the University of Iowa (Science 1951, PMID 14834873), through Nicholas Franks and William Lieb's hydrophobic-cavity hypothesis at Imperial College London (Nature 1998, Nat Rev Neurosci 2008), to modern clinical and preclinical work: xenon as NMDA glycine-site antagonist and TREK-1 activator (Maze 2003 Br Med Bull, Coburn 2018 Br J Anaesth, Goebel 2017 Anaesthesia); argon as HIF-1α-dependent neuroprotectant via the cellular hypoxic-response cascade (Loetscher 2009 Crit Care, Ulbrich 2014 PLoS One, Höllig 2014 Int J Mol Sci); the TREK-1 two-pore-domain potassium channel as the common molecular substrate uniting noble gases, volatile anesthetics, polyunsaturated fatty acids, and mechanical/thermal stress (Heurteaux 2006 Nat Neurosci, Gruss 2004 Mol Pharmacol); the lesser-studied pharmacology of helium (heliox in asthma, hyperpolarized ³He lung MRI), krypton (mild NMDA binding, clinical retinal photocoagulation laser line), and neon (no documented receptor binding but rich red-emission spectrum driving cytochrome c oxidase photobiomodulation); the 2026 Journal of Translational Medicine noble gas biology review consolidating five years of clinical translation data; a complete clinical-landscape table covering indication, evidence level, and regulatory status across xenon anesthesia (approved DE/RU/JP), neonatal hypoxic-ischemic encephalopathy neuroprotection (TOBYXe), traumatic brain injury, argon cardiac arrest protocols, helium heliox, and krypton retinal photocoagulation; and the convergence argument for the four gases inside a Tesla BioLights tube — argon (Ar), neon (Ne), krypton (Kr), xenon (Xe) — where the same hydrophobic-cavity chemistry that makes noble gases bind to NMDA receptors also places their plasma emission lines across the 600-1100 nm photobiomodulation window. The masterpiece edition.]]></description>
  </item>

  <item>
    <title>The 600-1100 nm Optical Window: Why Red and Near-Infrared Light Heal</title>
    <link>https://www.teslabiolights.com/blog/optical-window-600-1100nm-red-near-infrared-light/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/optical-window-600-1100nm-red-near-infrared-light/</guid>
    <pubDate>Tue, 26 May 2026 08:00:00 +0000</pubDate>
    <category>Photobiomodulation</category>
    <category>Optics</category>
    <category>Dosimetry</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[The optical window of biological tissue spans 600 to 1100 nanometers — the wavelength range where hemoglobin stops absorbing, melanin drops off, and water has not yet taken over. This essay walks through why red and near-infrared light penetrate human tissue at therapeutic depths, the Anderson-Parrish 1981 J Invest Dermatol optical-skin map that underwrites modern laser dermatology, half-attenuation depths from 633 nm (epidermis) to 1064 nm (outer cortex via skull, 5-8mm), the Huang-Hamblin 2009 Dose-Response biphasic curve that explains why high-wattage PBM backfires (Arndt-Schulz rule applied to photons), the fluence (J/cm²) and irradiance (mW/cm²) parameters that distinguish effective photobiomodulation from clinical noise, the laser-versus-LED coherence debate (now settled — wavelength and fluence matter, coherence does not), the FDA-cleared PBM devices in current practice (HairMax, LumiThera Valeda for AMD, Theralase, Smartlux), the Ferraresi-Hamblin 2016 muscle-tissue review supporting integration into sports recovery at Cleveland Clinic Sports Health and the Andrews Institute, and why the multi-wavelength noble-gas plasma emission of Tesla BioLights brackets the entire CCO action spectrum within the lower-to-middle hormetic range of the Arndt-Schulz curve.]]></description>
  </item>

  <item>
    <title>Mitochondria as Light Antennae: How Cytochrome c Oxidase Converts Photons Into ATP</title>
    <link>https://www.teslabiolights.com/blog/mitochondria-light-antennae-cytochrome-c-oxidase/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/mitochondria-light-antennae-cytochrome-c-oxidase/</guid>
    <pubDate>Mon, 25 May 2026 08:00:00 +0000</pubDate>
    <category>Photobiomodulation</category>
    <category>Mitochondria</category>
    <category>Cytochrome c Oxidase</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[Mitochondrial cytochrome c oxidase (CCO, Complex IV of the electron transport chain) is the canonical photoacceptor for red and near-infrared light between 600 and 1100 nm. Forty years of peer-reviewed work — from Tiina Karu's foundational action-spectrum measurements at the Russian Academy of Sciences (1980s-2000s), through Margaret Wong-Riley's 2005 J Biol Chem demonstration that 670nm light rescues neurons functionally inactivated by cyanide, to Michael Hamblin's 2016 IEEE JSTQE mechanism review (PMID 27885397), to Margaret Naeser's transcranial PBM TBI trials (2011 Photomed Laser Surg) — has established the molecular pathway: NIR photons absorbed at CCO's Cu_B copper center displace inhibitory nitric oxide, restoring electron transport and boosting ATP synthesis. Downstream: brief controlled ROS pulse activates Nrf2; NF-κB drives anti-apoptotic gene expression; mitochondrial biogenesis increases via PGC-1α. The FDA has issued 510(k) clearances for low-level light therapy across pain, hair regrowth, wound healing, and oral mucositis. This essay walks through the discovery story, the mechanism, the optical window of tissue (why 600-1100nm), the wavelength-target mapping (660nm preferentially binds heme, 810nm preferentially binds Cu_B, 1064nm reaches deeper tissue), and why noble-gas plasma emission from argon, neon, xenon, and krypton brackets the full Karu-Hamblin therapeutic band.]]></description>
  </item>

  <item>
    <title>Michael Levin at Tufts: The Bioelectric Code</title>
    <link>https://www.teslabiolights.com/blog/michael-levin-bioelectric-code-tufts/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/michael-levin-bioelectric-code-tufts/</guid>
    <pubDate>Thu, 21 May 2026 08:00:00 +0000</pubDate>
    <category>Lineage</category>
    <category>Levin</category>
    <category>Bioelectricity</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[Michael Levin's lab at Tufts University has spent two decades demonstrating that transmembrane voltage gradients across cells encode morphogenetic information — controlling tissue regeneration, body-plan formation, and tumor reversion. This profile covers his trajectory from frog left-right asymmetry studies through the Allen Discovery Center, the bioelectric-code framework, the planaria experiments producing stable two-headed worms, the eye induction in flank tissue (Pai et al. 2012), the melanoma reversion by voltage normalization (Chernet & Levin 2013), the xenobot results (Kriegman et al. 2020 PNAS), the Cognitive Light Cone framework with Daniel Dennett, and the position of bioelectricity as a foundational information layer. Why Levin gives Tesla BioLights the electric channel that runs alongside Popp's photonic channel.]]></description>
  </item>

  <item>
    <title>Fritz-Albert Popp: A Profile</title>
    <link>https://www.teslabiolights.com/blog/fritz-albert-popp-biophoton-profile/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/fritz-albert-popp-biophoton-profile/</guid>
    <pubDate>Thu, 21 May 2026 08:00:00 +0000</pubDate>
    <category>Lineage</category>
    <category>Popp</category>
    <category>Biophotonics</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[Fritz-Albert Popp (1938-2018) was the German theoretical physicist who spent four decades measuring single-photon emission from living cells, demonstrated coherence properties consistent with DNA as a primary source, and built the International Institute of Biophysics in Neuss, Germany — a global research network spanning approximately 19 laboratories across 13 countries. This profile covers his trajectory from carcinogen research to biophoton discovery in 1976, the measured properties of biophoton emission (10-1000 photons/cm²/s across 200-800nm, hyperbolic decay, sub-Poissonian statistics consistent with coherence), the IIB collaborators (Beloussov, Van Wijk, Mae-Wan Ho, Niggli, and others), the Fröhlich coherent-oscillation theoretical framework, and the post-Popp peer-reviewed literature (Devaraj 2017 PMC5491638, Esposito 2019 PMC6429109, Salari 2017 PNAS, Kobayashi 2009 PLoS ONE on human biophoton circadian rhythms). Closes with why Popp's research provides the foundational physics premise for the Tesla BioLights S.E.A.D. System.]]></description>
  </item>

  <item>
    <title>Royal Rife, Honestly</title>
    <link>https://www.teslabiolights.com/blog/royal-rife-honestly/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/royal-rife-honestly/</guid>
    <pubDate>Tue, 19 May 2026 08:00:00 +0000</pubDate>
    <category>Lineage</category>
    <category>Rife</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[Royal Rife (1888-1971) is the most famous name in the electromedicine lineage and the most carelessly cited. This essay walks through what Rife actually built in 1930s San Diego — the Universal Microscope, the Beam Ray Tube, the 1934 USC Special Medical Research Committee clinical study — separates the documented from the disputed (the original USC paperwork has never been independently located in the archives), and explains where Tesla BioLights stands on the Rife legacy: cautiously rather than enthusiastically, with honest reasons for both halves. Covers the AMA conflict with Morris Fishbein, the 1939 Beam Ray Corporation lawsuit, the 1947 laboratory fire, and the modern bioelectromagnetics literature (acoustic-resonance spectroscopy of microbes, cold atmospheric plasma medicine) that partially vindicates the general category and partially does not.]]></description>
  </item>

  <item>
    <title>The Antoine Priore Files: France's State-Funded Plasma Therapy</title>
    <link>https://www.teslabiolights.com/blog/antoine-priore-cnrs-plasma-therapy-files/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/antoine-priore-cnrs-plasma-therapy-files/</guid>
    <pubDate>Mon, 18 May 2026 08:00:00 +0000</pubDate>
    <category>Lineage</category>
    <category>Priore</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[In 1960s Bordeaux, an Italian-French radar operator named Antoine Priore built a plasma-tube device that reportedly produced complete remission of terminal cancer in hundreds of animal experiments. The work was funded by the French government, conducted at the University of Bordeaux with CNRS researchers, supported by Prime Minister Jacques Chaban-Delmas himself, and published in peer-reviewed French journals (Comptes Rendus de l'Académie des Sciences) from 1965 to 1974. Then in 1974, after political turnover and mechanism opacity, the program ended. This essay covers the device specifications (plasma tube + 1200 Gauss magnetic field + 9.4 GHz magnetron + dual HF oscillators), the published animal studies, the state-funded chapter, and what the Priore affair means for the modern Tesla BioLights lineage.]]></description>
  </item>

  <item>
    <title>Georges Lakhovsky and the Multi-Wave Oscillator: The 1920s Paris Chapter</title>
    <link>https://www.teslabiolights.com/blog/georges-lakhovsky-multi-wave-oscillator/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/georges-lakhovsky-multi-wave-oscillator/</guid>
    <pubDate>Sun, 17 May 2026 08:00:00 +0000</pubDate>
    <category>Lineage</category>
    <category>Lakhovsky</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[In the 1920s, Russian-French engineer Georges Lakhovsky took Tesla's coil and asked a question no physicist of the era thought to ask: what if cells are themselves resonant electrical circuits? His device — the Multi-Wave Oscillator — was used in Paris hospitals, his thesis published in his 1925 book The Secret of Life, then dismissed for fifty years. Modern bioelectric research at Tufts (Michael Levin) and Fröhlich's coherent oscillation theory have since vindicated the core idea. This essay covers the man, the device, the Paris hospital deployments, the long dismissal, and the engineering connection from MWO to today's S.E.A.D. System.]]></description>
  </item>

  <item>
    <title>The Tesla Coil at 135: Why Nikola Tesla's 1891 Patent Still Matters</title>
    <link>https://www.teslabiolights.com/blog/tesla-coil-1891-patent-why-it-still-matters/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/tesla-coil-1891-patent-why-it-still-matters/</guid>
    <pubDate>Sat, 16 May 2026 08:00:00 +0000</pubDate>
    <category>Lineage</category>
    <category>Tesla</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[In 1891, Nikola Tesla patented a resonant high-voltage transformer that produced high-frequency alternating current. One hundred and thirty-five years later, that circuit is still inside everything from radio transmitters to MRI scanners to the S.E.A.D. System. This essay covers what Tesla actually invented, how it works, his own 1898 paper on electrotherapeutic applications (PMID 29693867), and why the same circuit drives noble gas plasma in Tesla BioLights today.]]></description>
  </item>

  <item>
    <title>The Science of Biophotons: How Cells Communicate Through Light</title>
    <link>https://www.teslabiolights.com/blog/science-of-biophotons-how-cells-communicate-through-light/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/science-of-biophotons-how-cells-communicate-through-light/</guid>
    <pubDate>Fri, 15 May 2026 08:00:00 +0000</pubDate>
    <category>Biophotonics</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[Living cells emit single photons. They are not random. Three decades of measurements by German biophysicist Fritz-Albert Popp suggest these biophotons are coherent, originate primarily from DNA, and may serve as a cellular signaling channel. This is the foundation underneath the entire Tesla BioLights premise.]]></description>
  </item>

  <item>
    <title>Noble Gases, Plasma Light, and Why Tesla BioLights Picks Argon, Neon, Xenon, Krypton</title>
    <link>https://www.teslabiolights.com/blog/noble-gases-photobiomodulation-plasma-light/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/noble-gases-photobiomodulation-plasma-light/</guid>
    <pubDate>Fri, 15 May 2026 08:00:00 +0000</pubDate>
    <category>Plasma Physics</category>
    <category>Photobiomodulation</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[When noble gases ionize, each one emits a specific, characteristic spectrum of light. Those spectra overlap meaningfully with the wavelengths your mitochondria already know how to use. The choice of gases inside Tesla BioLights is not aesthetic. It is spectral.]]></description>
  </item>

  <item>
    <title>Beyond the Glow: How Pulsed Electromagnetic Fields Actually Work</title>
    <link>https://www.teslabiolights.com/blog/pemf-pulsed-electromagnetic-field-tesla-coil/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/pemf-pulsed-electromagnetic-field-tesla-coil/</guid>
    <pubDate>Fri, 15 May 2026 08:00:00 +0000</pubDate>
    <category>PEMF</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[The visible plasma is the half of Tesla BioLights you can see. The pulsed electromagnetic field is the half you cannot. PEMF has been FDA-cleared for bone non-union healing since 1979. What is finally being mapped is the mechanism: adenosine receptors, ion cyclotron resonance, Wnt/β-catenin pathways, calcium signaling.]]></description>
  </item>

  <item>
    <title>The Bioelectric Code: How Electromagnetic Fields Interface With Cellular Health</title>
    <link>https://www.teslabiolights.com/blog/bioelectric-code-electromagnetic-fields-cellular-health/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/bioelectric-code-electromagnetic-fields-cellular-health/</guid>
    <pubDate>Fri, 15 May 2026 08:00:00 +0000</pubDate>
    <category>Bioelectricity</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[Every cell has a voltage. Voltage gradients across membranes are not just an artifact of metabolism — they are an information channel. Michael Levin's lab at Tufts University has spent two decades demonstrating that this bioelectric code controls morphogenesis itself.]]></description>
  </item>

  <item>
    <title>DNA Activation, Bioenergetics, and the Honest Frontier</title>
    <link>https://www.teslabiolights.com/blog/dna-activation-bioenergetics-frontier-science/</link>
    <guid isPermaLink="true">https://www.teslabiolights.com/blog/dna-activation-bioenergetics-frontier-science/</guid>
    <pubDate>Fri, 15 May 2026 08:00:00 +0000</pubDate>
    <category>Synthesis</category>
    <dc:creator>Tesla BioLights</dc:creator>
    <description><![CDATA[The internet says wild things about Tesla BioLights. Here is what the peer-reviewed science actually supports, what it does not, and where the honest scientific line sits. A critical synthesis essay.]]></description>
  </item>

</channel>
</rss>
